Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Intercept Pharmaceuticals, Inc.

NASDAQ: ICPTHealthcare / Biotechnology / USA
106.60+4.34+4.24%Vol 221 1941Y Perf 71.53%
Dec 10th, 2018 15:34
BID106.45 ASK106.72
Open102.33 Previous Close102.26
Pre-Market- After-Trading102.26
 - -%  - -%
Target Price
135.48 
Analyst Rating
Moderate Buy 1.83
Potencial %
26.96 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-100/-64 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/-76 
Growth Ranking
     37.69
Insiders Shares Cnt. % 3/6/12M
-100/-100/-64 
Income Ranking
 —    -
Market Cap (mil)3 161 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
67.18 
Earnings Date
31st Oct 2018

Today's Price Range

100.68106.99

 

52wk Range

51.05133.74

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Month
-10.13%
3 Months
-8.96%
6 Months
34.20%
1 Year
71.53%
3 Years
-35.33%
5 Years
77.26%

Quotes

Name / TickerPriceChg.Chg.%
ICPT106.604.34004.24
AAPL169.460.97000.58
GOOG1 046.139.55000.92
MSFT107.853.03002.89
XOM76.43-1.2100-1.56
WFC49.08-1.1800-2.35
JNJ145.650.22000.15
FB142.515.09003.70
GE6.91-0.1000-1.43
JPM101.69-1.6000-1.55
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
5.80
Current Ratio
6.00
Long Term Debt to Total Capital
0.79
Total Debt to Equity
3.83
Interest Coverage
-10.00
Leverage Ratio 9.90
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
98.60
EBIT Margin
-184.10
EBITDA Margin
-181.10
Pre-tax Profit Margin
-6 101.60
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
34.33
PS Ratios
20.03
Price to Cash Flow
-
Price to Free Cash Flow
-12.40
Cash Flow Per Share
-9.67
Price to Tangible Book
34.33
Book Value per Share
3.23
Enterprise Value (in ths.)
3 167 120
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-106.22
ROE last 12 Months
-320.53
Return on Assets (5Y Avg)
-48.35
ROA last 12 Months
-59.52
Return on Capital (5Y Avg)
-88.16
ROC last 12 Months
-65.24
Return on invested Capital Q
-11.67
Return on invested Capital Y
-64.39
Assets Turnover
0.10
Receivables Turnover
4.50
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
164 211
Revenue per Share
5.54
Revenue Growth 3 Years
281.10
Revenue Growth 5 Years
177.89
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-2.65-2.1817.74
Q02 2018-2.83-2.588.83
Q01 2018-3.41-3.225.57
Q04 2017-3.57-4.43-24.09
Q03 2017-3.55-2.8918.59
Q02 2017-3.62-3.464.42
Q01 2017-4.27-3.6115.46
Q04 2016-3.58-4.84-35.20
Earnings Per EndEstimateRevision %Trend
12/2018 QR-2.454.67Positive
12/2018 FY-10.354.70Positive
3/2019 QR-2.246.67Positive
12/2019 FY-7.695.30Positive
Next Report Date-
Estimated EPS Next Report-2.65
Estimates Count9
EPS Growth Next 5 Years %-
Volume Overview
Volume221 194
Shares Outstanding (in ths.)29 650
Trades Count1 501
Dollar Volume19 025 724
Avg. Volume653 029
Avg. Weekly Volume343 885
Avg. Monthly Volume377 211
Avg. Quarterly Volume453 432

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

46%54%

Bearish Bullish

69%31%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (58.33 %)
6 (50.00 %)
6 (46.15 %)
Moderate Buy
1 (8.33 %)
1 (8.33 %)
0 (0.00 %)
Hold
3 (25.00 %)
4 (33.33 %)
6 (46.15 %)
Moderate Sell
1 (8.33 %)
1 (8.33 %)
1 (7.69 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.83
Moderate Buy
2.00
Moderate Buy
2.15

There are no comments yet.

News